<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/131BC483-0A92-40F5-A15E-0A687D7CC55A"><gtr:id>131BC483-0A92-40F5-A15E-0A687D7CC55A</gtr:id><gtr:name>Papua New Guinea Inst of Med Research</gtr:name><gtr:address><gtr:line1>Papua New Guinea Institute of Medical Re</gtr:line1><gtr:line2>PO Box 60</gtr:line2><gtr:postCode>EHP 441</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A21478EA-E506-4B64-A8A9-42CD8D97C635"><gtr:id>A21478EA-E506-4B64-A8A9-42CD8D97C635</gtr:id><gtr:name>University College London Hospital (UCLH) NHS Foundation Trust</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C1ED9692-B6AE-4778-BF31-AE813E8E4415"><gtr:id>C1ED9692-B6AE-4778-BF31-AE813E8E4415</gtr:id><gtr:name>MRC Prion Unit</gtr:name><gtr:address><gtr:line1>MRC Prion Unit</gtr:line1><gtr:line2>Institute of Neurology</gtr:line2><gtr:line3>Queen Square</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>WC1N 3BG</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1ED9692-B6AE-4778-BF31-AE813E8E4415"><gtr:id>C1ED9692-B6AE-4778-BF31-AE813E8E4415</gtr:id><gtr:name>MRC Prion Unit</gtr:name><gtr:address><gtr:line1>MRC Prion Unit</gtr:line1><gtr:line2>Institute of Neurology</gtr:line2><gtr:line3>Queen Square</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>WC1N 3BG</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/131BC483-0A92-40F5-A15E-0A687D7CC55A"><gtr:id>131BC483-0A92-40F5-A15E-0A687D7CC55A</gtr:id><gtr:name>Papua New Guinea Inst of Med Research</gtr:name><gtr:address><gtr:line1>Papua New Guinea Institute of Medical Re</gtr:line1><gtr:line2>PO Box 60</gtr:line2><gtr:postCode>EHP 441</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A21478EA-E506-4B64-A8A9-42CD8D97C635"><gtr:id>A21478EA-E506-4B64-A8A9-42CD8D97C635</gtr:id><gtr:name>University College London Hospital (UCLH) NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0E953CEB-E92F-4800-AFDB-D7FB776FE5B5"><gtr:id>0E953CEB-E92F-4800-AFDB-D7FB776FE5B5</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Collinge</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8387B948-74F7-4EA3-9C2F-2AD83C2DFC31"><gtr:id>8387B948-74F7-4EA3-9C2F-2AD83C2DFC31</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Alpers</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U123160657"><gtr:id>F9737736-2A62-428B-844F-CB539678B189</gtr:id><gtr:title>Clinical Research Studies in the UK and PNG</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U123160657</gtr:grantReference><gtr:abstractText>Kuru is one of a closely related group of brain diseases which affect both humans and animals known as the transmissible spongiform encephalopathies or prion diseases. Animal prion diseases include scrapie, a naturally occurring disease affecting sheep and goats, which has been recognised for over 200 years and is present in many countries world-wide, and the much more recently recognised bovine spongiform encephalopathy (BSE) (mad cow disease) amongst cattle. The human prion diseases include Creutzfeldt-Jakob disease (CJD) and kuru. Kuru provides the principal experience of an epidemic human prion disease. It has steadily declined in incidence following the abrupt cessation of its route of transmission, endocannibalism, in Papua New Guinea in the 1950s. BSE transmitted to humans causes variant CJD. The unknown prevalence of infection following the extensive dietary exposure to BSE prions in the UK has led to renewed interest in kuru, particularly with respect to the range of possible incubation periods and the effect of genetic susceptibility factors. Present studies are ongoing to record the maximum incubation period for kuru. Epidemiological studies that include genetic and anthropological data are being conducted to help us fully understand the kuru epidemic and its implications for the variant Creutzfeldt-Jakob disease epidemic.</gtr:abstractText><gtr:technicalSummary>Kuru is one of a closely related group of neurodegenerative conditions which affect both humans and animals known as the transmissible spongiform encephalopathies or prion diseases. Animal prion diseases include scrapie, a naturally occurring disease affecting sheep and goats, which has been recognised for over 200 years and is present in many countries world-wide, and the much more recently recognised bovine spongiform encephalopathy (BSE) amongst cattle. The human prion diseases have been traditionally classified into Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler-Sheinker syndrome (GSS) and kuru. Kuru provides the principal experience of an epidemic human prion disease. It has steadily declined in incidence following the abrupt cessation of its route of transmission, endocannibalism, in Papua New Guinea in the 1950s. The arrival of the novel acquired prion disease, variant CJD, and the unknown prevalence of infection following the extensive dietary exposure to BSE prions in the UK, has led to renewed interest in kuru, particularly with respect to the range of possible incubation periods and the effect of genetic susceptibility factors. That the incubation period of infection acquired by dietary exposure to human prions can exceed 50 years, as found in kuru, suggests the need for caution with respect to predictions of vCJD epidemic size and duration based on the numbers of clinical cases seen to date. Infection of humans with cattle BSE prions involves cross-species, rather than within-species transmission, which would further increase the mean and range of incubation periods. The research activities have seven major aims. (1) Identify and study all remaining kuru patients: document the maximum incubation periods: We have studied the clinical features of recent kuru patients and compared clinical and other diagnostic features with other human prion diseases, notably iatrogenic and variant CJD. Surveillance for new patients is ongoing. (2) Epidemiological analysis of kuru records: Data will be analysed for standard epidemiological variables and differences in geographical area. (3) Document mortuary feast practices and traditional beliefs of the aetiology of kuru by interview of surviving participants and other members of the Fore community: A large number of interviews have been conducted and are being analysed. More interviews are planned to expand the cultural and geographical range of the study and to probe deeper into the details of the mortuary rites. (4) To investigate for any evidence of maternal or other routes of kuru transmission: From the data available we conclude that maternal transmission was not a feature of kuru. The data on mortuary practices do not support a high probability of parenteral transmission. Thus the common route of transmission was undoubtedly oral. (5) Genetic susceptibility: details of laboratory studies are given under Unit Human Molecular Genetics research programme. (6) Peripheral pathogenesis, tissue distribution and investigation of possibility of asymptomatic carriers of kuru: Tissues obtained from a kuru autopsy are under intense investigation. We will interview elderly survivors of the kuru epidemic in all affected linguistic groups to look at factors affecting the transmission of kuru. We aim to obtain autopsies when these older people die to determine whether any were asymptomatic carriers of kuru. (7) Data archive and bibliography: A full inventory will be made of all the kuru and kuru-related files. When the appropriate equipment is available archival and contemporary footage will be combined and edited on digital format for making teaching films on kuru, of varying length and complexity suitable for medical educational purposes.</gtr:technicalSummary><gtr:fund><gtr:end>2017-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>5459998</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Neurophysiology of prion disease</gtr:description><gtr:id>7998A125-1DBB-4E73-83DF-FA7EF1D42F45</gtr:id><gtr:impact>Contribution to National Prion Monitoring Cohort study publications</gtr:impact><gtr:outcomeId>CSpdzEGvp2g-1</gtr:outcomeId><gtr:partnerContribution>EEG and EMG study of prion disease patients</gtr:partnerContribution><gtr:piContribution>National Prion Clinic staff collect clinical and investigation data.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Papua New Guinea Institute of Medical Research</gtr:collaboratingOrganisation><gtr:country>Papua New Guinea, Independent State of</gtr:country><gtr:description>Kuru Field Studies Project</gtr:description><gtr:id>E7B80D7F-5559-4171-BBD9-A7F368CA1BE1</gtr:id><gtr:impact>The collaboration has produced important information about a completed epidemic of human prion disease, and demonstrated the long incubation periods that can occur in human prion disease. It has discovered a protective genetic variant that the kuru epidemic has selected for, a dramatic demonstration of human evolution in action. The epidemic has led to a balancing selection in a related human genetic polymorphism and further investigation of this has provided evidence for kuru-like epidemics in the remote human past. All the publications in section 1 have resulted, to a lesser or larger extent, from this collaboration. This collaboration is multi-disciplinary, with significant contributions from the disciplines of clinical neurology, neuropathology, molecular biology, epidemiology, human genetics and anthropology.</gtr:impact><gtr:outcomeId>AE2FC33065E-1</gtr:outcomeId><gtr:partnerContribution>They have provided an administrative base in Goroka for our field studies and a field base in Waisa in the South Fore. They have facilitated our contacts with the health and other authorities in Papua New Guinea. They have provided logistical support to our work and helped to ensure good relations with local communities.</gtr:partnerContribution><gtr:piContribution>We have provided the supervision of all field studies and have led the field team in epidemiological surveillance, in clinical and genetic studies, and in ethnographic and human behavioural investigations. We have provided training to the staff of the project.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Neuroimaging of prion disease</gtr:description><gtr:id>E2101FAA-1711-4CCF-A09A-0FE4F756A7C8</gtr:id><gtr:impact>The first large clinical trial in human prion diseases. 19081515</gtr:impact><gtr:outcomeId>4712B5A3D98-1</gtr:outcomeId><gtr:partnerContribution>Expertise in neuroimagingMRC CTU contribute statistical and clinical trials expertise</gtr:partnerContribution><gtr:piContribution>MRC CTU contribute statistical and clinical trials expertise. The clinical trial and similar studies are conducted by National Prion Clinic staff</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Trials Unit</gtr:department><gtr:description>Clinical Trial and Cohort studies with MRC CTU</gtr:description><gtr:id>399F905E-D028-4C85-B89D-298085158988</gtr:id><gtr:impact>The first large clinical trial in human prion disease. 19081515</gtr:impact><gtr:outcomeId>A0DB7ED2E85-1</gtr:outcomeId><gtr:partnerContribution>MRC CTU contribute statistical and clinical trials expertise</gtr:partnerContribution><gtr:piContribution>MRC CTU contribute statistical and clinical trials expertise. The data collection is done by National Prion Clinic staff</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Trials Unit</gtr:department><gtr:description>Neuroimaging of prion disease</gtr:description><gtr:id>E615F664-22AD-4F5B-AF89-64A2905F4A54</gtr:id><gtr:impact>The first large clinical trial in human prion diseases. 19081515</gtr:impact><gtr:outcomeId>4712B5A3D98-2</gtr:outcomeId><gtr:partnerContribution>Expertise in neuroimagingMRC CTU contribute statistical and clinical trials expertise</gtr:partnerContribution><gtr:piContribution>MRC CTU contribute statistical and clinical trials expertise. The clinical trial and similar studies are conducted by National Prion Clinic staff</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Interview for Daily Telegraph (27 April 2013)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8F61EA87-BE5F-4C58-8A49-1FB4AC02E890</gtr:id><gtr:impact>Interview for the Daily Telegraph regarding Human Exposure to BSE and prevalence of CJD. Resulted in a front page news item in the Daily Telegraph.

Prompted further media enquiries increasing public awareness of the issue.</gtr:impact><gtr:outcomeId>PvZuubERi7t</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview for BBC Radio 4 Today (19 November 2009)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7550DFD8-BFD8-457D-8AFB-75A4FBAFB2D7</gtr:id><gtr:impact>Interview for Today, BBC Radio 4, regarding the publication of the following paper

Mead S, Whitfield J, Poulter M, Shah P, Uphill J, Campbell T, Al-Doujaily H, Hummerich H, Beck J, Mein C, Verzilli C, Whittaker J, Alpers M, Collinge J. A novel protective prion protein variant co-localises with kuru exposure. N Engl J Med 2009; 361: 2056-65.

The interview, along with a press release, generated significant media interest including articles in national newspapers such as the Times

Interview and increased media interest serve to widen public awareness of the Unit's work.</gtr:impact><gtr:outcomeId>JTwoXLcboBe</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Interview, Today Programme BBC Radio 4 (3 February 2011)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F8DD5470-DE99-4BEF-80B0-C66C580018C1</gtr:id><gtr:impact>Interviewed on the Today programme, BBC Radio 4, about the publication of the Unit's work on a new CJD blood test. The interview, along with a press release, generated a series of articles in national newspapers and websites.

The interview served to increase public awareness of the blood test and CJD prevalence.</gtr:impact><gtr:outcomeId>cQ88mswS2J8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Member of special panel during CJD Support Network (Australia)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0073A63A-F603-4660-BD31-953F5F4B0D5A</gtr:id><gtr:impact>Served as panel member on special session entitled 'Patient Care, Diagnostics, Genetic CJD and Treatment Trails'. Discussions were conducted in front of an audience of 130 patients and family members

Patient group feedback indicated heightened knowledge of this disease as a result of workshop</gtr:impact><gtr:outcomeId>NamoMuPDT6X</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Centenary Open Day (20 June 2013)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2348DBA5-76D3-4A2A-8E00-60526C2BE415</gtr:id><gtr:impact>Approximately 100 members of the public attended the Prion Unit's Centenary Open Day on 20 June 2013. The presentations prompted a series of questions from patient's families regarding the Unit's current research and aims.

The open date resulted in enquiries from the National Media, including a filmed television interview for ITN News.</gtr:impact><gtr:outcomeId>pz9GBNSXaAt</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited presentation to USA patient group</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>76E430A2-F472-45B6-B733-AA7FBF7DE6F8</gtr:id><gtr:impact>Invited presentation to USA patient group

N/A</gtr:impact><gtr:outcomeId>9C5BF636C98</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Comment and edits for an article published in The Global Mail (13 November 2012)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>384A69FF-36EE-4125-BD94-36C558CE55AF</gtr:id><gtr:impact>Comment and edits for an article entitled 'Last Laughing Death' on Professor Michael Alpers' career researching Kuru in Papua New Guinea

Publication in Global Mail, an international online publication. Such articles serve to increase public awareness of research.</gtr:impact><gtr:outcomeId>XB3bRs4iN1E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release for Dementia Chip Paper (20 February 2013)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3FC08CC5-24F5-4593-BF63-2B87B3637C4F</gtr:id><gtr:impact>Press release for the following paper:

Beck J, Pittman A, Adamson G, Campbell T, Kenny J, Houlden H, Rohrer JD, de Silva R, Shoai M, Uphill J, Poulter M, Hardy J, Mummery CJ, Warren JD, Schott JM, Fox NC, Rossor MN, Collinge J, Mead S. Validation of next generation sequencing technologies in genetic diagnosis of dementia. Neurobiol Aging 2013, (published online ahead of print).

Increased media awareness of paper.</gtr:impact><gtr:outcomeId>bAs5LAFRMBD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Prion Unit and NHS National Prion Clinic Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>13E72B11-DE4A-4430-9566-8112E8F2F031</gtr:id><gtr:impact>Detailed presentation on research strategy and update for patients, familes, carers and health professionals with question and answer session, lab tours and informal discussions with research staff and students

Obtaining feedback on our work, communicating our research and services, building good relationships with our patient group</gtr:impact><gtr:outcomeId>1E8B8330168</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release for Lancet Blood Test paper (1 February 2011)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BE33854B-075E-44D2-ACC0-B54437214B38</gtr:id><gtr:impact>Press release regarding the publication of the following paper: 

Edgeworth JA, Farmer M, Sicilia A, Tavares P, Beck J, Campbell T, Lowe J, Mead S, Rudge P, Collinge J, Jackson GS. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 2011; 377:487-93.

The press release generated a wide-range of media interest resulting in articles published in national newspapers and websites including: The Guardian, BBC News, The Telegraph, The Express, The Daily Mail, The Scotsman and The MIrror.

The resulting media coverage served to raise public awareness of the paper and the Unit's work.</gtr:impact><gtr:outcomeId>e2oG5qTtgJU</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media interest (Comment for Readers Digest article)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>818DF906-45D4-4ACF-9379-343E921D4FFC</gtr:id><gtr:impact>Provided comment on human exposure to BSE for an article published in Readers Digest.

Raising awareness of the work undertaken by MRC</gtr:impact><gtr:outcomeId>QfRugk5AMpx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Teaching / lectures</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E9887811-7BB2-4770-A971-3FEA6ED84301</gtr:id><gtr:impact>National Prion Clinic staff visit an NHS facility and disseminate good practice and update staff on our research objectives. Around 30-50 of these visits are done in a typical year. At a minimum this involves staff at a small Unit like a ward or nursing home, but might also include a presentation to a University Medical School entire staff.

Increased awareness.</gtr:impact><gtr:outcomeId>8B2F13FA772</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with Channel 4 News (14 January 2012)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>157C3D25-04BD-4CDB-A9B9-6FF066F34837</gtr:id><gtr:impact>Interview with Channel 4 News regarding the Prion Unit and The National Prion Clinic offering a CJD blood test.

Interview served to raise public awareness of the test</gtr:impact><gtr:outcomeId>H3kJnZgKhUo</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>AAN Annual Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>96F1706C-7E6B-4829-9FA8-567ECDD5F18E</gtr:id><gtr:impact>Presented talk to Annual Meeting of the American Academy of Neurology &amp;quot;Development of rational therapeutics for prion infection and its relevance to Alzheimer's disease&amp;quot;</gtr:impact><gtr:outcomeId>58c7deea836071.70071053</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society Meeting on kuru - discussion with media</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1EB1A0EA-700E-4FDF-9746-D758D92FFBFA</gtr:id><gtr:impact>Discussion with representatives of the media about the meeting to celebrate the end of kuru attended by collaborators and those effected by the disease.

Article in &amp;quot;Times&amp;quot; newspaper was published</gtr:impact><gtr:outcomeId>07F2629AB61</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview for BBC Newsnight (29 March 2011)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0A49F8E1-597D-43D1-B23A-70FF39E109BD</gtr:id><gtr:impact>An interview BBC newsnight regarding surgical decontamination and CJD infection. The interview was broadcast as part of a special feature on the issue.

The interview served to raise public awareness of the issues surrounding surgical decontamination.</gtr:impact><gtr:outcomeId>ERqJcKv3GiM</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with Daily Mail (1 November 2011)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3424F890-DD47-4585-A202-DBE447137185</gtr:id><gtr:impact>Interview with the Daily Mail on infectious prions and blood donors. Resulted in an article being published in a National Newspaper.

The interview served to raise public awareness of the issue of Prion disease carriers and blood donations.</gtr:impact><gtr:outcomeId>RxuCbRbc6pB</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>National Prion Clinic, Patients and Families Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D0A0CB7E-1069-49B9-AE1D-04B71A787A3D</gtr:id><gtr:impact>Talk sparked questions and discussions afterwards &amp;amp; obtaining feedback from patients and their families.

Feedback resulted in our providing increased councelling services.</gtr:impact><gtr:outcomeId>545a02d00f16f1.50495278</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Clinic Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F22AE51F-02B7-4393-80AD-61E024181A05</gtr:id><gtr:impact>Update on patients and carers on the Unit's work</gtr:impact><gtr:outcomeId>58c13e0f139a75.96865033</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press Release for NEJM Kuru Paper (18 November 2009)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4B40501B-C6DD-4EC6-8B05-20A165BAF923</gtr:id><gtr:impact>Press release for the following paper:

Mead S, Whitfield J, Poulter M, Shah P, Uphill J, Campbell T, Al-Doujaily H, Hummerich H, Beck J, Mein C, Verzilli C, Whittaker J, Alpers M, Collinge J. A novel protective prion protein variant co-localises with kuru exposure. N Engl J Med 2009; 361: 2056-65.

Media interest including an interview for the BBC Radio 4 and article in The Times newspaper. Served to increase public awareness of the Unit's work.</gtr:impact><gtr:outcomeId>oWsj3c7kjfW</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Podcast</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E52337E5-FA58-4D5E-BDFB-0908CFB513DD</gtr:id><gtr:impact>Recorded podcast for Nature Podcast re journal article on kuru</gtr:impact><gtr:outcomeId>56d6e9a0a1dff7.32875162</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>23ACFCF4-559B-4EF6-A09B-E172758A1FD3</gtr:id><gtr:impact>Interviewed by journalist from Bio Century Publications; regarding published journal article on prion resistance among the Fore of PNG</gtr:impact><gtr:outcomeId>56d6eb33bea2b8.35085500</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ANA lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FC3CDDDC-DF8A-4143-8FC1-AD6239D6975F</gtr:id><gtr:impact>Presented a lecture at the American Neurological Association AGM. &amp;quot;Prion Diseases: The classical view&amp;quot;</gtr:impact><gtr:outcomeId>56d83e0abeec63.70560198</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with Sky News (3 February 2011)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>ACE1FDAD-84B2-4C90-B309-8F25043283B3</gtr:id><gtr:impact>Interview with Sky News regarding the Unit's CJD Blood Test.

Interview raised public awareness of the blood test and the Unit's work.</gtr:impact><gtr:outcomeId>amqnecAr2MM</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presented to CJD Foundation Family Support Group</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1A4779ED-1C5E-485B-84B9-F8C6D2979A42</gtr:id><gtr:impact>Approx 50 patient family members attended talk.

Patient group feedback indicated heightened knowledge of this disease as a result of presentation.</gtr:impact><gtr:outcomeId>YPvgbeQQqBP</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient/Families Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B04E36EB-DDED-47D2-946B-77CE2304BB33</gtr:id><gtr:impact>Clinic open day, provided an update on the Unit's research and objectives.</gtr:impact><gtr:outcomeId>56d6e5b68593c2.42356101</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release for PNAS paper (26 July 2009)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5BCE49A1-6691-4974-825E-89DC42C46005</gtr:id><gtr:impact>Press release for the following paper:

Edgeworth J, Gros N, Alden J, Joiner S, Wadsworth JDF, Linehan J, Brandner S, Jackson GS, Weissmann C, Collinge J. Spontaneous generation of mammalian prions. Proc Natl Acad Sci U S A. 2010; 107:14402-6.



Increased media awareness including this video http://www.youtube.com/watch?v=eEC8Ifi6cv0 which raises public awareness of Unit's work</gtr:impact><gtr:outcomeId>hc6A9koCnj1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>611666</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Biomedical Research Unit</gtr:department><gtr:description>NIHR Biomedical Research Unit for Dementia: Molecular Mechanisms theme</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Barts Health NHS Trust</gtr:fundingOrg><gtr:id>AD496981-3374-47F6-AF8B-FD58776E4F6C</gtr:id><gtr:outcomeId>Fo6WJYTmQrF</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>UCLH/UCL Biomedical Research Centre</gtr:department><gtr:description>UCLH Biomedical Research Centre</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>E9BBEE63-208B-4DB3-A36C-22D0E53325CF</gtr:id><gtr:outcomeId>SJVc1F7n5Yp0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>National Prion Monitoring Cohort</gtr:description><gtr:end>2015-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>7258712B-3728-4277-BEB9-D0BC631A3525</gtr:id><gtr:outcomeId>E1212A859180</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Clinical research output</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>1B80FF84-2670-44C1-9368-ED80FA5F9F0F</gtr:id><gtr:outcomeId>81221BA9CA9</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Briefing to PUS for Health re current CJD research</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>85263CE6-75B0-488B-BFA0-DE67670394F3</gtr:id><gtr:outcomeId>Qh7qN8oBtR9</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Parliamentary Select Committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>12DF07FA-D3EC-4DCE-9AEA-DE9CB1853891</gtr:id><gtr:outcomeId>5458a86a508f70.24429538</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Briefing to PUS for Health &amp;amp; CMO on vCJD research</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E2D72733-5452-4D27-9B71-7352EACB05BD</gtr:id><gtr:outcomeId>nQshRdz4Y5g</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Attendance of Committees</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AF40D1C7-5776-4F17-82E1-788E80562549</gtr:id><gtr:outcomeId>R9kR7GcCEPW</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Clinical service for genetic testing of dementia genes received from both national and international institutions</gtr:description><gtr:id>08604572-6A0B-49D9-B41A-0EE1F2A1CB04</gtr:id><gtr:impact>Clinical service for genetic testing of dementia genes received from both national and international institutions</gtr:impact><gtr:outcomeId>gBBEKkEPiNF</gtr:outcomeId><gtr:stage>Wide-scale adoption</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Genetic testing of dementia genes</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type></gtr:productOutput><gtr:productOutput><gtr:description>A screening test that enables precise detection of vCJD infection.</gtr:description><gtr:id>AF07EF0B-3AEA-484D-AA81-1827AF7A2AC2</gtr:id><gtr:impact>A screening test that enables precise detection of vCJD infection.</gtr:impact><gtr:outcomeId>Y24yUUZXtFk</gtr:outcomeId><gtr:stage>Small-scale adoption</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Blood Test for vCJD</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2011</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>420F9D63-C4B6-4F08-81F9-1512746106C4</gtr:id><gtr:title>Kuru in the 21st century--an acquired human prion disease with very long incubation periods.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a46902526a5df5054ffa4a1bb4ba33a6"><gtr:id>a46902526a5df5054ffa4a1bb4ba33a6</gtr:id><gtr:otherNames>Collinge J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>hnpw7MmsGPK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7F0198A-D2A9-484A-834F-F9747841F8A7</gtr:id><gtr:title>Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2425c10daa4923f9040e1a5332915e6e"><gtr:id>2425c10daa4923f9040e1a5332915e6e</gtr:id><gtr:otherNames>Kaski DN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>qdpXAsL14AM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD1DA7B8-22A0-4E42-BAC5-951A4187D977</gtr:id><gtr:title>High-b-value diffusion MR imaging and basal nuclei apparent diffusion coefficient measurements in variant and sporadic Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>AJNR. American journal of neuroradiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2df16c0b13c37700a2c612d047aa21f4"><gtr:id>2df16c0b13c37700a2c612d047aa21f4</gtr:id><gtr:otherNames>Hyare H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0195-6108</gtr:issn><gtr:outcomeId>Kor7oFQapsq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65DF85A7-D7F5-4FB4-A8F2-A8C09D6DCEAE</gtr:id><gtr:title>Variant CJD in an individual heterozygous for PRNP codon 129.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/558cfebca4cb53657fc6621e5d136d8a"><gtr:id>558cfebca4cb53657fc6621e5d136d8a</gtr:id><gtr:otherNames>Kaski D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>rGv8nZ73U2D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72DC6754-104E-4AD6-98D6-10670AAE8967</gtr:id><gtr:title>Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>58bec7749fcfa7.71543895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF1F14A0-BA1E-4512-8409-2D90FA7E8796</gtr:id><gtr:title>A novel protective prion protein variant that colocalizes with kuru exposure.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>SPyc3DBB3WV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6706D89C-CA22-4871-B4C8-36D215DB6880</gtr:id><gtr:title>Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66af904a27f77da84a6a4d64a502057e"><gtr:id>66af904a27f77da84a6a4d64a502057e</gtr:id><gtr:otherNames>McNaughton D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_14431_21_21193246</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21EBD416-B514-40C6-8B43-16BACE7EB1CC</gtr:id><gtr:title>Seven-year discordance in age at onset in monozygotic twins with inherited prion disease (P102L).</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc91402d504020448ea53946ad57bcaa"><gtr:id>fc91402d504020448ea53946ad57bcaa</gtr:id><gtr:otherNames>Webb T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>aCHBcJc8SWV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1FDD07B-1ECA-4ABF-8EFB-642C10B1949A</gtr:id><gtr:title>Predictive testing for inherited prion disease: report of 22 years experience.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d47ad451beb379d16b15c48e905cf90"><gtr:id>9d47ad451beb379d16b15c48e905cf90</gtr:id><gtr:otherNames>Owen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>544fb7ae565c24.24468787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A824B00-E625-4EF3-BB88-A01EE11C8E36</gtr:id><gtr:title>Autoantibodies in Sporadic Creutzfeldt-Jakob Disease</gtr:title><gtr:parentPublicationTitle>JAMA Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b741ada569a250435aca20c3646d362"><gtr:id>9b741ada569a250435aca20c3646d362</gtr:id><gtr:otherNames>Angus-Leppan H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>pm_14431_21_23699783</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7D57DE9-2B96-4D35-BDE4-6C48D69394FC</gtr:id><gtr:title>Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a46902526a5df5054ffa4a1bb4ba33a6"><gtr:id>a46902526a5df5054ffa4a1bb4ba33a6</gtr:id><gtr:otherNames>Collinge J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>1B6F6BF2070</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B74AB22B-921A-4A29-9D9F-368A46504CF2</gtr:id><gtr:title>Collinge et al. reply.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a46902526a5df5054ffa4a1bb4ba33a6"><gtr:id>a46902526a5df5054ffa4a1bb4ba33a6</gtr:id><gtr:otherNames>Collinge J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>58bec062404e83.68983255</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01E39E2E-E089-463F-A279-20276092570F</gtr:id><gtr:title>Variant Creutzfeldt-Jakob disease with extremely low lymphoreticular deposition of prion protein.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>544fb7ad588b10.74621164</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62FFB779-3DF1-42A0-9FF7-8F2311643D73</gtr:id><gtr:title>Behavioral and psychiatric symptoms in prion disease.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b2e606c7abd26ebb7b86026fa391727"><gtr:id>8b2e606c7abd26ebb7b86026fa391727</gtr:id><gtr:otherNames>Thompson A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn><gtr:outcomeId>544fb7ad89c408.71424322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>987F1EBC-FE33-4BEE-8F9D-1F0119D4611E</gtr:id><gtr:title>Corticobasal syndrome associated with a novel 1048_1049insG progranulin mutation.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>Q22aJRk4bNs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70BC06DD-3B65-4709-AEFB-66A7FA2951A7</gtr:id><gtr:title>Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5ee5a13f7d6b0787d4919dd19ba893a"><gtr:id>c5ee5a13f7d6b0787d4919dd19ba893a</gtr:id><gtr:otherNames>Rossi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>544fb7b047e787.82486335</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF9001AD-3B1A-4B98-8E61-71C1F234CF0A</gtr:id><gtr:title>Evidence for human transmission of amyloid-? pathology and cerebral amyloid angiopathy.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46f5fbd4a8def22591a116738bda4515"><gtr:id>46f5fbd4a8def22591a116738bda4515</gtr:id><gtr:otherNames>Jaunmuktane Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56d5a0e993a294.33407800</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF3388B9-425E-4638-A3EA-67C624855AD6</gtr:id><gtr:title>Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01510dcd2c16ce1aeba88470243237a4"><gtr:id>01510dcd2c16ce1aeba88470243237a4</gtr:id><gtr:otherNames>Rudge P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56d5a0123adcd2.56574798</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CF167D7-AA5E-4F5A-B8AB-C79E17294484</gtr:id><gtr:title>Collinge et al. reply.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a46902526a5df5054ffa4a1bb4ba33a6"><gtr:id>a46902526a5df5054ffa4a1bb4ba33a6</gtr:id><gtr:otherNames>Collinge J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>58bec061c53f20.09924384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B673BE58-AE22-4052-A10C-FC9155EC835F</gtr:id><gtr:title>Quantitative EEG parameters correlate with the progression of human prion diseases.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93cdbb2f82402ae3559e93ad831c327b"><gtr:id>93cdbb2f82402ae3559e93ad831c327b</gtr:id><gtr:otherNames>Franko E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>58bec0620cf6f9.65833111</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5093EA43-D968-4A11-AA61-9CBA2985DC38</gtr:id><gtr:title>11C-PiB PET does not detect PrP-amyloid in prion disease patients including variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2df16c0b13c37700a2c612d047aa21f4"><gtr:id>2df16c0b13c37700a2c612d047aa21f4</gtr:id><gtr:otherNames>Hyare H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>Mft87grCr8M</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88A29680-5EEF-4708-BDDF-81B128A3DBE9</gtr:id><gtr:title>Tau, prions and A?: the triad of neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48400a296d38fca43225c28bd85f67c0"><gtr:id>48400a296d38fca43225c28bd85f67c0</gtr:id><gtr:otherNames>Reiniger L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>MmeRoXEhm7b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5008F77A-C649-41D3-8E3C-E77B463F95CD</gtr:id><gtr:title>Variant Creutzfeldt-Jakob Disease in a Patient with Heterozygosity at PRNP Codon 129.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/809b4086fcbd8d5c1c06308f735111f0"><gtr:id>809b4086fcbd8d5c1c06308f735111f0</gtr:id><gtr:otherNames>Mok T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>58be72dc524512.78434597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09A5937B-6CFE-44E2-8A00-C3A41DA64139</gtr:id><gtr:title>MRI detection of prion protein plaques in variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2df16c0b13c37700a2c612d047aa21f4"><gtr:id>2df16c0b13c37700a2c612d047aa21f4</gtr:id><gtr:otherNames>Hyare H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>56d59e8ac23bc9.92472896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B32CA084-C4E4-4242-8FFC-069CC729A42C</gtr:id><gtr:title>Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>LxyWYTXJ8XP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D401FDF-8A9F-45B6-8C27-40B3E631945C</gtr:id><gtr:title>Familial Alzheimer's disease and inherited prion disease in the UK are poorly ascertained.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/abc3f233f373ed02719f6b6d5e5fa937"><gtr:id>abc3f233f373ed02719f6b6d5e5fa937</gtr:id><gtr:otherNames>Stevens JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>GiiZF8oK2hr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD7FCABC-A5EC-4097-8A3E-5DD61B8FD97B</gtr:id><gtr:title>Magnetization transfer ratio may be a surrogate of spongiform change in human prion diseases.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38527d70804a784836d7a6d4c221e299"><gtr:id>38527d70804a784836d7a6d4c221e299</gtr:id><gtr:otherNames>Siddique D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>HYKaxeThrwY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE2046FE-AAC3-4136-991B-BA6CCCE9C146</gtr:id><gtr:title>Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/124a2925167cbee690b074d32a622cc8"><gtr:id>124a2925167cbee690b074d32a622cc8</gtr:id><gtr:otherNames>Brandner S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>gX37F69iAHF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9AAA7E1-B4C5-4C42-B78F-8B957D531BA6</gtr:id><gtr:title>Some tributes to research colleagues and other contributors to our knowledge about kuru.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44ba86d6dbccb031fb97b8e13b5edb2a"><gtr:id>44ba86d6dbccb031fb97b8e13b5edb2a</gtr:id><gtr:otherNames>Alpers MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>7F962B13030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3231DAE9-1811-4ADB-9464-FEF5C3FC5D0F</gtr:id><gtr:title>Review. The epidemiology of kuru: monitoring the epidemic from its peak to its end.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44ba86d6dbccb031fb97b8e13b5edb2a"><gtr:id>44ba86d6dbccb031fb97b8e13b5edb2a</gtr:id><gtr:otherNames>Alpers MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>F3D9D2AA55D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>748560B4-CB48-4453-B7A4-913F8A00C63C</gtr:id><gtr:title>Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d7b7e2fe78d5e2742820eea3aa14ddd"><gtr:id>5d7b7e2fe78d5e2742820eea3aa14ddd</gtr:id><gtr:otherNames>Edgeworth JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>WnPuBhDxDeY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAF81DB6-358E-44ED-8CBA-6A6F8ACFBEE8</gtr:id><gtr:title>Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29a9c2586c68901d5c8cc3129e94e33d"><gtr:id>29a9c2586c68901d5c8cc3129e94e33d</gtr:id><gtr:otherNames>Schott JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>58bec774ee4681.22607863</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C54DB85D-F73B-46BA-8100-D7FD1103D5FD</gtr:id><gtr:title>The cognitive profile of prion disease: a prospective clinical and imaging study.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12a3e35a0773314c3afbe39a364c5bee"><gtr:id>12a3e35a0773314c3afbe39a364c5bee</gtr:id><gtr:otherNames>Caine D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn><gtr:outcomeId>56d5a0120ba1e9.53467109</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1216AE4-20C9-4B4C-9261-BBDF9E31817B</gtr:id><gtr:title>Mortuary rites of the South Fore and kuru.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd4f863695dcba46da68aa615c2ca4db"><gtr:id>bd4f863695dcba46da68aa615c2ca4db</gtr:id><gtr:otherNames>Whitfield JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>5B0EEAE69B2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E27CB05-264F-44AD-9DDC-CD9CB60FACAC</gtr:id><gtr:title>Validation of next-generation sequencing technologies in genetic diagnosis of dementia.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_14431_21_23998997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48663F47-F0B5-46B6-B6C1-9FA4568988A0</gtr:id><gtr:title>Review. The origin of the prion agent of kuru: molecular and biological strain typing.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25db88fcbd041997bffe5354e9a3b87e"><gtr:id>25db88fcbd041997bffe5354e9a3b87e</gtr:id><gtr:otherNames>Wadsworth JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>MSauh5Z1W7a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26EACE2A-7894-4415-8D3E-A36976BF9111</gtr:id><gtr:title>Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07e74972561be40ab721f911617b3191"><gtr:id>07e74972561be40ab721f911617b3191</gtr:id><gtr:otherNames>Lambert JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_14431_21_24162737</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE60FF1B-1248-4DC5-9B5D-636F90F22E82</gtr:id><gtr:title>FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab9e3dde384013eef79f476bf114e0e9"><gtr:id>ab9e3dde384013eef79f476bf114e0e9</gtr:id><gtr:otherNames>Urwin H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>CBJ8yxYXD9d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>339DC327-0896-48BA-B401-E329A3E52EC4</gtr:id><gtr:title>Comment on validation of diagnostic criteria for variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44154794c63211aac745864409e98d53"><gtr:id>44154794c63211aac745864409e98d53</gtr:id><gtr:otherNames>Lukic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>cMM7o1U6bsd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA205803-861F-471C-8950-A7E318BE069F</gtr:id><gtr:title>MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>BMC neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5c31182cd1a4acdea4acac66e5ce433"><gtr:id>c5c31182cd1a4acdea4acac66e5ce433</gtr:id><gtr:otherNames>Carswell C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2377</gtr:issn><gtr:outcomeId>pm_14431_21_23216655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>537C6977-2FB6-4771-9B5F-4612C6A507A3</gtr:id><gtr:title>Neuroanatomical correlates of prion disease progression - a 3T longitudinal voxel-based morphometry study.</gtr:title><gtr:parentPublicationTitle>NeuroImage. Clinical</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f043ed1cf2c55a840962d924232b9925"><gtr:id>f043ed1cf2c55a840962d924232b9925</gtr:id><gtr:otherNames>De Vita E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2213-1582</gtr:issn><gtr:outcomeId>58be732ade3e92.09474414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E045D66-E9BB-46D8-82A0-8BA5D6123DB6</gtr:id><gtr:title>Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob Disease.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>58bec06269b643.28628715</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B152C6E6-66C0-45F4-9DD3-7D8A3F227BFC</gtr:id><gtr:title>Distinct neuropsychological profiles correspond to distribution of cortical thinning in inherited prion disease caused by insertional mutation.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71580ef822aa97e50703ee41546f9747"><gtr:id>71580ef822aa97e50703ee41546f9747</gtr:id><gtr:otherNames>Alner K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>Vb8eDryvqJF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B141D1E1-797D-47D6-8CB4-4C842D57A685</gtr:id><gtr:title>A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a46902526a5df5054ffa4a1bb4ba33a6"><gtr:id>a46902526a5df5054ffa4a1bb4ba33a6</gtr:id><gtr:otherNames>Collinge J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>EA5799B5D20</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>82297202-446C-44B2-AF43-D3C4A37351C7</gtr:id><gtr:title>Cognitive impairment in the preclinical stage of dementia in FTD-3 CHMP2B mutation carriers: a longitudinal prospective study.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50f440bad2db7293a597baaa7cc0d812"><gtr:id>50f440bad2db7293a597baaa7cc0d812</gtr:id><gtr:otherNames>Stokholm J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_14431_21_23142962</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FEF3B10F-419A-4889-9BFC-5516A2E9FC2B</gtr:id><gtr:title>Heterozygosity at polymorphic codon 219 in variant creutzfeldt-jakob disease.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44154794c63211aac745864409e98d53"><gtr:id>44154794c63211aac745864409e98d53</gtr:id><gtr:otherNames>Lukic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>BnpAo5rqH9m</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7868CA07-02E7-468E-84B4-5F1029D9843E</gtr:id><gtr:title>The role of variation at A?PP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/719950cfe57960088e8c4cb5aaf09b14"><gtr:id>719950cfe57960088e8c4cb5aaf09b14</gtr:id><gtr:otherNames>Gerrish A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm_14431_21_22027014</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A08297A-10AB-4A99-85B4-F9543183C3B1</gtr:id><gtr:title>The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a31927906cffc4c4cbf31a0c8fd63195"><gtr:id>a31927906cffc4c4cbf31a0c8fd63195</gtr:id><gtr:otherNames>Thompson AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_14431_21_23550114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>383D2377-4D1A-4B01-9A97-DA02C912FCC9</gtr:id><gtr:title>Genetic susceptibility, evolution and the kuru epidemic.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>gZuNBTeFXmU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>477D1CA2-B835-487E-B4FD-5B0FACC10233</gtr:id><gtr:title>PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5cfdf106876171606d0edeedb5461e8f"><gtr:id>5cfdf106876171606d0edeedb5461e8f</gtr:id><gtr:otherNames>Beck JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>aSkVniz56Js</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F286C770-7071-4983-96EE-8D7647672B31</gtr:id><gtr:title>PRION-1 scales analysis supports use of functional outcome measures in prion disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>J1VDRC6b6Sa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D44A78D4-F7F3-41D7-B563-668B23F5D1FE</gtr:id><gtr:title>A history of kuru.</gtr:title><gtr:parentPublicationTitle>Papua and New Guinea medical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44ba86d6dbccb031fb97b8e13b5edb2a"><gtr:id>44ba86d6dbccb031fb97b8e13b5edb2a</gtr:id><gtr:otherNames>Alpers MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0031-1480</gtr:issn><gtr:outcomeId>C0EBB4AF49A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1952141-B539-4882-A5E0-FCD89EBD27C1</gtr:id><gtr:title>Review. Lessons of kuru research: background to recent studies with some personal reflections.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a46902526a5df5054ffa4a1bb4ba33a6"><gtr:id>a46902526a5df5054ffa4a1bb4ba33a6</gtr:id><gtr:otherNames>Collinge J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>1863C4486AB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>277762F4-F06D-4DEE-AB2B-6A8A4B79B526</gtr:id><gtr:title>Genome-wide association study of Alzheimer's disease with psychotic symptoms.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b52384d0266bc60ddab21c962b93cc25"><gtr:id>b52384d0266bc60ddab21c962b93cc25</gtr:id><gtr:otherNames>Hollingworth P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>pm_14431_21_22005930</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C45A9EE0-FCAE-4359-94D2-076E8EE66882</gtr:id><gtr:title>Variants of PLCXD3 are not associated with variant or sporadic Creutzfeldt-Jakob disease in a large international study.</gtr:title><gtr:parentPublicationTitle>BMC medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb87f110bb4914af0973f4d8272af1b6"><gtr:id>bb87f110bb4914af0973f4d8272af1b6</gtr:id><gtr:otherNames>Balendra R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2350</gtr:issn><gtr:outcomeId>58bec774c66296.87267458</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4EFC83B-17F6-486C-8482-1F5912FB48D6</gtr:id><gtr:title>Reversal of pathology in CHMP2B-mediated frontotemporal dementia patient cells using RNA interference.</gtr:title><gtr:parentPublicationTitle>The journal of gene medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6817cf39c35b603be3577d48c7163b6b"><gtr:id>6817cf39c35b603be3577d48c7163b6b</gtr:id><gtr:otherNames>Nielsen TT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1099-498X</gtr:issn><gtr:outcomeId>pm_14431_21_22786763</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC7C320C-B2FF-482E-9B5F-586AFF7C7681</gtr:id><gtr:title>Multiparameter MR imaging in the 6-OPRI variant of inherited prion disease.</gtr:title><gtr:parentPublicationTitle>AJNR. American journal of neuroradiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f043ed1cf2c55a840962d924232b9925"><gtr:id>f043ed1cf2c55a840962d924232b9925</gtr:id><gtr:otherNames>De Vita E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0195-6108</gtr:issn><gtr:outcomeId>pm_14431_21_23538406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5A661AB-C133-4346-A78C-47AD228E3AC7</gtr:id><gtr:title>Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/102d9843eeefde06c7a21180b72c418b"><gtr:id>102d9843eeefde06c7a21180b72c418b</gtr:id><gtr:otherNames>Eisenmenger L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>58bec77530a7d4.83035404</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B4DA8A5-5302-4E9F-A75C-0D377B3EA564</gtr:id><gtr:title>Cultural factors that affected the spatial and temporal epidemiology of kuru.</gtr:title><gtr:parentPublicationTitle>Royal Society open science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd4f863695dcba46da68aa615c2ca4db"><gtr:id>bd4f863695dcba46da68aa615c2ca4db</gtr:id><gtr:otherNames>Whitfield JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2054-5703</gtr:issn><gtr:outcomeId>5a9fa67d281c81.34190839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC9C76DF-7CB4-433E-A4FC-4A34CBEF61D3</gtr:id><gtr:title>Video Rating in Neurodegenerative Disease Clinical Trials: The Experience of PRION-1.</gtr:title><gtr:parentPublicationTitle>Dementia and geriatric cognitive disorders extra</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5c31182cd1a4acdea4acac66e5ce433"><gtr:id>c5c31182cd1a4acdea4acac66e5ce433</gtr:id><gtr:otherNames>Carswell C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1664-5464</gtr:issn><gtr:outcomeId>pm_14431_21_22962552</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U123160657</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>2472941E-25F2-45EC-A735-3C0872CE6B26</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.3  Psychological, social and economic factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>